BMRBj - Statistics

1 bmr: 52339

Abl 1b isoform wild type SH3-SH2-KD (aa 83-534) in complex with imatinib

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-534)
Entity: 1. SH3SH2KD(83-534), entity 1 (polymer, Thiol state: all free), 454 monomers, 51695.93 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKELG KQGV

2. SH3SH2KD(83-534), entity STI (non-polymer), 493.603 Da
Total weight: 52189.53 Da
Max. entity weight: 51695.93 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-02-25
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

2 bmr: 52310

Abl 1b isoform wild type SH3-SH2-KD (aa 83-534) in complex with PD166326

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-534) in complex with PD166326
Entity: 1. SH3SH2KD(83-534) in complex with PD166326, entity 1 (polymer, Thiol state: all free), 454 monomers, 51695.93 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKELG KQGV

2. SH3SH2KD(83-534) in complex with PD166326, entity P16 (non-polymer), 427.283 Da
Total weight: 52123.21 Da
Max. entity weight: 51695.93 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-02-05
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

3 bmr: 52307

Abl 1b isoform wild type SH3-SH2-KD (aa 83-534) in complex with GNF-5

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-534) in complex with GNF-5
Entity: 1. SH3SH2KD(83-534) in complex with GNF-5, entity 1 (polymer, Thiol state: all free), 454 monomers, 51695.93 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKELG KQGV

2. SH3SH2KD(83-534) in complex with GNF-5, entity 2 (non-polymer, Thiol state: not present), na Da
Formula weight: 51695.93 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-02-04
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

4 bmr: 52306

Abl 1b isoform E528K SH3-SH2-KD (aa 83-534) in complex with imatinib

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: E528K SH3SH2KD(83-534) in complex with imatinib
Entity: 1. E528K SH3SH2KD(83-534) in complex with imatinib, entity 1 (polymer, Thiol state: all free), 454 monomers, 51694.99 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKKLG KQGV

2. E528K SH3SH2KD(83-534) in complex with imatinib, entity STI (non-polymer), 493.603 Da
Total weight: 52188.59 Da
Max. entity weight: 51694.99 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-02-04
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

5 bmr: 52305

Abl 1b isoform E528K SH3-SH2-KD (aa 83-534) apo

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: E528K SH3SH2KD(83-534)
Entity: 1. E528K SH3SH2KD(83-534) (polymer, Thiol state: all free), 454 monomers, 51694.99 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKKLG KQGV
Formula weight: 51694.99 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-02-04
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

6 bmr: 52300

Abl 1b isoform wild type SH3-SH2-KD (aa 83-517) in complex with imatinib

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-517)
Entity: 1. SH3SH2KD(83-517), entity 1 (polymer, Thiol state: all free), 437 monomers, 49880.00 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQ

2. SH3SH2KD(83-517), entity STI (non-polymer), 493.603 Da
Total weight: 50373.6 Da
Max. entity weight: 49880.0 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-02-04
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

7 bmr: 52298

Abl 1b isoform wild type SH3-SH2-KD (aa 83-517) apo

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-517)
Entity: 1. SH3SH2KD(83-517) (polymer, Thiol state: all free), 437 monomers, 49880.00 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQ
Formula weight: 49880.0 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-01-31
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

8 bmr: 52297

Abl 1b isoform wild type SH3-SH2-KD (aa 83-519) in complex with imatinib

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-519)
Entity: 1. SH3SH2KD(83-519), entity 1 (polymer, Thiol state: all free), 439 monomers, 50160.24 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAYK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQES

2. SH3SH2KD(83-519), entity STI (non-polymer), 493.603 Da
Total weight: 50653.84 Da
Max. entity weight: 50160.24 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-01-31
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

9 bmr: 52296

Abl 1b isoform wild type SH3-SH2-KD (aa 83-519) apo

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-519)
Entity: 1. SH3SH2KD(83-519) (polymer, Thiol state: all free), 439 monomers, 50096.20 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQES
Formula weight: 50096.2 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-01-31
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

10 bmr: 52293

Abl 1b isoform wild type SH3-SH2-KD (aa 83-534) in complex with asciminib

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-534)+Asciminib
Entity: 1. SH3SH2KD(83-534)+Asciminib, entity 1 (polymer, Thiol state: all free), 454 monomers, 51695.93 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKELG KQGV

2. SH3SH2KD(83-534)+Asciminib, entity AY7 (non-polymer), 449.838 Da
Total weight: 52145.77 Da
Max. entity weight: 51695.93 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-01-29
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

11 bmr: 52273

Abl 1b isoform wild type SH3-SH2-KD (aa 83-534) apo

Authors: Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
Assembly: SH3SH2KD(83-534)
Entity: 1. SH3SH2KD(83-534) (polymer, Thiol state: all free), 454 monomers, 51695.93 Da Detail
GPNLFVALYD FVASGDNTLS ITKGEKLRVL GYNHNGEWCE AQTKNGQGWV PSNYITPVNS LEKHSWYHGP VSRNAAEYLL SSGINGSFLV RESESSPGQR SISLRYEGRV YHYRINTASD GKLYVSSESR FNTLAELVHH HSTVADGLIT TLHYPAPKRN KPTVYGVSPN YDKWEMERTD ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS DRPSFAEIHQ AFETMFQESS ISDEVEKELG KQGV
Formula weight: 51695.93 Da
Source organism: Homo sapiens
Exptl. method: solution NMR
Data set: assigned_chemical_shifts
Release date: 2024-01-17
Citation: The molecular basis of Abelson kinase regulation by its aI-helix
Paladini, J., Maier, A., Habazettl, J.M., Hertel, I., Sonti, R., Grzesiek, S.
eLife (2023), DOI https://doi.org/10.7554/eLife.92324.1

Keywords Abelson tyrosine kinase, cancer, chronic myelogenous leukemia, allosteric activation, aI-helix, asciminib, NMR

12 bmr: 52308

Backbone chemical shift assignments of human ZNF706

Authors: Sahoo, Bikash R, Bardwell, James
Release date: 2024-04-17

13 bmr: 51320

Backbone and sidechain 1H, 13C, 15N chemical shift assignments for the isolated human HtrA2-PDZ domain

Authors: Aspholm, Emelie, Burmann, Bjorn
Release date: 2024-04-17

Year	BMRB (US+JP)	BMRB (US)	BMRBj (JP)
1996	1220	1220
1997	62	62
1998	156	156
1999	227	227
2000	168	168
2001	32	32
2002	118	118
2003	332	332
2004	390	390
2005	483	463	20
2006	560	501	59
2007	668	563	105
2008	746	562	184
2009	665	607	58
2010	1055	718	337
2011	820	774	46
2012	818	750	68
2013	799	745	54
2014	771	714	57
2015	770	687	83
2016	697	594	103
2017	711	634	77
2018	763	698	65
2019	748	711	37
2020	988	893	95
2021	934	830	104
2022	714	676	38
2023	715	676	39
2024	220	219	1
Total	17350	15720	1630

Year	BMRB (US+JP)	BMRB (US)	BMRBj (JP)	Withdrawn (awd, obs, sa)
1995	1204	1204
1996	16	16
1997	62	62
1998	163	163		2
1999	221	221
2000	196	196
2001	3	3
2002	118	118		3
2003	335	335		3
2004	389	389		9
2005	504	486	18	30
2006	546	487	59	40
2007	695	576	119	45
2008	738	506	232	38
2009	667	560	107	44
2010	1074	727	347	59
2011	843	779	64	47
2012	822	754	68	50
2013	836	787	49	43
2014	738	696	42	42
2015	776	751	25	55
2016	769	698	71	38
2017	793	677	116	41
2018	776	678	98	28
2019	825	736	89	30
2020	974	863	111	69
2021	909	822	87	60
2022	758	673	85	27
2023	781	675	106	44
2024	252	226	26	9
Total	17783	15864	1919	856

Statistics of BMRB entries

Release date: 2024-04-18

1 bmr: 52339

2 bmr: 52310

3 bmr: 52307

4 bmr: 52306

5 bmr: 52305

6 bmr: 52300

7 bmr: 52298

8 bmr: 52297

9 bmr: 52296

10 bmr: 52293

11 bmr: 52273

Release date: 2024-04-17

12 bmr: 52308

13 bmr: 51320

BMRB core archive (NMR-STAR)

BMRBj search service (BMRB/XML)

BMRB core archive (NMR-STAR)

BMRB core archive (NMR-STAR)